Jackson Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,502
| Closed | -$1.41M | – | 178 |
|
|
2024
Q4 | $1.41M | Sell |
3,502
-46
| -1% | -$18.5K | 0.16% | 82 |
|
|
2024
Q3 | $1.65M | Buy |
3,548
+1,682
| +90% | +$782K | 0.2% | 79 |
|
|
2024
Q2 | $875K | Sell |
1,866
-1,689
| -48% | -$792K | 0.19% | 82 |
|
|
2024
Q1 | $1.49M | Buy |
3,555
+46
| +1% | +$19.2K | 0.19% | 79 |
|
|
2023
Q4 | $1.43M | Buy |
3,509
+56
| +2% | +$22.8K | 0.19% | 78 |
|
|
2023
Q3 | $1.2M | Sell |
3,453
-62
| -2% | -$21.6K | 0.17% | 80 |
|
|
2023
Q2 | $1.24M | Buy |
3,515
+67
| +2% | +$23.6K | 0.18% | 75 |
|
|
2023
Q1 | $1.09M | Buy |
+3,448
| New | +$1.09M | 0.82% | 46 |
|
|
2022
Q4 | – | Sell |
-4,880
| Closed | -$1.41M | – | 110 |
|
|
2022
Q3 | $1.41M | Buy |
4,880
+3,187
| +188% | +$923K | 0.28% | 69 |
|
|
2022
Q2 | $477K | Buy |
+1,693
| New | +$477K | 0.22% | 77 |
|